Iridex Corp (IRIX) Stock Price, Quote & News

Company Profile

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems th...

Industry: Medical Devices

Sector: Healthcare

Phone: 650 940 4700

Fax: 650 940 4710

Website: www.iridex.com

Address:

1212 Terra Bella Avenue, Mountain View, United States

Sidoti Dec. 11 at 6:32 PM

The Iridex Corporation ($IRIX) Management Team presented today at the Sidoti Year End Virtual Conference. Watch the replay here: https://sidoti.zoom.us/webinar/register/WN_ECZq8XevRqKfHf0YiznumA

0 · Reply

JohnTrack Dec. 11 at 4:08 PM

$IRIX watching for higher lows...

0 · Reply

Sidoti Dec. 11 at 3:32 PM

Day 2: Presenting at 10:45am at our Year End conference $IRIX $LZM $OBL https://buff.ly/lJdSLvw

0 · Reply

JohnTrack Dec. 11 at 12:17 PM

$IRIX new publication https://www.rapidticker.com/news/irix-iridex-announces-the-publication-of-e685dc

0 · Reply

10baggerPete Dec. 10 at 7:40 PM

$IRIX added based on the continued insider buying, I don't think tax loss selling will get it much lower. Bottom is in imho!

0 · Reply

Thestocktraderhubzee Dec. 8 at 12:16 PM

$IRIX Iridex Announces Newly Published Study In Translational Vision Science & Technology Examining Thermal Dynamics Of Transscleral Laser Treatments For Glaucoma

0 · Reply

DARKP00L Dec. 8 at 12:14 PM

$IRIX 07:08 on Dec. 08 2025 Iridex Announces Newly Published Study In Translational Vision Science & Technology Examining Thermal Dynamics Of Transscleral Laser Treatments For Glaucoma #tradeideas

1 · Reply

Suki444 Dec. 2 at 8:14 AM

$IRIX silent before the storm? Buyout in progress? $AMZN

0 · Reply

StudBull Dec. 1 at 8:49 PM

$IRIX Iridex is scheduled to present at Sidoti's Year End Virtual Investor Conference Thurs Dec 11th @ 10:45am Link to company list and (free) conference registration: https://www.meetmax.com/sched/event_127859/__co-list_cp.html

0 · Reply

StudBull Nov. 19 at 4:01 PM

$IRIX New Form 4 filing - Director William Moore buys another 50,000 shares via open market purchases

0 · Reply

Iridex Announces the Publication of an Independent Study Demonstrating Safe and Effective Retreatment with Transscleral Laser Treatment Using MicroPulse® Technology in Glaucoma Management

Dec 8, 2025, 7:00 AM EST - 5 days ago

Iridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potential of MicroPulse® Technology and Continuous-Wave Laser for Glaucoma Treatment

Dec 5, 2025, 7:00 AM EST - 8 days ago

Iridex to Present at the Sidoti Year-End Virtual Investor Conference

Nov 11, 2025, 6:51 PM EST - 4 weeks ago

IRIDEX Corporation (IRIX) Q3 2025 Earnings Call Prepared Remarks Transcript

Nov 11, 2025, 4:05 PM EST - 4 weeks ago

Iridex Reports Third Quarter 2025 Financial Results

Oct 28, 2025, 4:05 PM EDT - 6 weeks ago

Iridex to Report Third Quarter 2025 Financial Results on November 11, 2025

Sep 9, 2025, 4:05 PM EDT - 3 months ago

Iridex Corporation Receives Formal Notification of Nasdaq Listing Compliance

Aug 12, 2025, 9:09 PM EDT - 4 months ago

IRIDEX Corporation (IRIX) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 4:05 PM EDT - 4 months ago

Iridex Reports Second Quarter 2025 Financial Results

Jun 24, 2025, 7:00 AM EDT - 6 months ago

Iridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse® Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema

May 13, 2025, 9:05 PM EDT - 7 months ago

IRIDEX Corporation, Inc. (IRIX) Q1 2025 Earnings Call Transcript

May 13, 2025, 4:05 PM EDT - 7 months ago

Iridex Reports First Quarter 2025 Financial Results

May 1, 2025, 6:00 PM EDT - 8 months ago

IRIDEX Changes Course

Apr 30, 2025, 4:05 PM EDT - 8 months ago

Iridex to Report First Quarter 2025 Financial Results on May 13, 2025

Apr 16, 2025, 7:11 PM EDT - 8 months ago

IRIDEX Corporation (IRIX) Strategic Vision Conference Call (Transcript)

Apr 9, 2025, 4:05 PM EDT - 8 months ago

Iridex to Host Strategic Vision Call on April 16, 2025

Mar 27, 2025, 6:03 PM EDT - 9 months ago

IRIDEX Corporation (IRIX) Q4 2024 Earnings Call Transcript

Mar 27, 2025, 4:05 PM EDT - 9 months ago

Iridex Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 19, 2025, 9:15 AM EDT - 9 months ago

Iridex Announces Strategic Investment in the Company

Mar 14, 2025, 7:00 AM EDT - 9 months ago

Iridex Comments on Recent Stock Price Volatility

Mar 13, 2025, 5:00 PM EDT - 9 months ago

Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025

Dec 18, 2024, 4:05 PM EST - 1 year ago

Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management

Nov 19, 2024, 8:14 AM EST - 1 year ago

Iridex Comments on Changing Glaucoma Reimbursement Landscape

Nov 16, 2024, 3:53 PM EST - 1 year ago

IRIDEX Corporation (IRIX) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 4:05 PM EST - 1 year ago

Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024

Oct 3, 2024, 4:05 PM EDT - 1 year ago

Iridex Appoints Patrick Mercer as Chief Executive Officer

Aug 26, 2024, 11:16 AM EDT - 1 year ago

Iridex Frustrates, But Expect A Transaction By Year-End

Aug 10, 2024, 4:23 PM EDT - 1 year ago

IRIDEX Corporation (IRIX) Q2 2024 Earnings Call Transcript

May 17, 2024, 3:27 PM EDT - 1 year ago

IRIDEX Corporation (IRIX) Q1 2024 Earnings Call Transcript

May 14, 2024, 4:05 PM EDT - 1 year ago

Iridex Reports First Quarter 2024 Financial Results

Mar 28, 2024, 7:12 PM EDT - 1 year ago

Iridex's Strategic Review Process Should Bear Fruit 'Soon'

Mar 26, 2024, 7:30 PM EDT - 1 year ago

IRIDEX Corporation (IRIX) Q4 2023 Earnings Call Transcript

Mar 26, 2024, 4:05 PM EDT - 1 year ago

Iridex Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 20, 2024, 4:05 PM EDT - 1 year ago

Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024

Jan 24, 2024, 8:00 AM EST - 2 years ago

Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust

Jan 11, 2024, 6:45 PM EST - 2 years ago

Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma

Dec 28, 2023, 6:00 PM EST - 2 years ago

Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation

Nov 27, 2023, 9:00 AM EST - 2 years ago

Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation

Nov 14, 2023, 4:21 PM EST - 2 years ago

Iridex Reports Third Quarter 2023 Financial Results and Business Update

Nov 13, 2023, 9:00 AM EST - 2 years ago

Iridex to Host Third Quarter Financial Results Conference Call on November 14, 2023

Nov 2, 2023, 6:11 AM EDT - 2 years ago

Iridex Reimbursement Chaos Presents Buying Opportunity

Oct 26, 2023, 4:22 PM EDT - 2 years ago

Iridex to Report Third Quarter Financial Results on November 14, 2023

Oct 4, 2023, 5:04 AM EDT - 2 years ago

Iridex: The Whole Is Less Than The Sum Of The Parts

Aug 29, 2023, 4:05 PM EDT - 2 years ago

Iridex Announces Strategic Review to Unlock Shareholder Value

Aug 10, 2023, 8:33 PM EDT - 2 years ago

IRIDEX Corporation (IRIX) Q2 2023 Earnings Call Transcript

Apr 27, 2023, 4:05 PM EDT - 2 years ago

Iridex to Report First Quarter Financial Results on May 11, 2023

Mar 9, 2023, 10:12 PM EST - 3 years ago

IRIDEX Corporation (IRIX) Q4 2022 Earnings Call Transcript

Mar 9, 2023, 4:05 PM EST - 3 years ago

Iridex Reports Fourth Quarter and Full Year 2022 Financial Results

Mar 7, 2023, 4:05 PM EST - 3 years ago

Iridex to Present at the 35th Annual Roth Conference

Mar 2, 2023, 9:00 AM EST - 3 years ago

Iridex Introduces New Research and Showcases Five Events at the AGS Meeting

Sidoti Dec. 11 at 6:32 PM

The Iridex Corporation ($IRIX) Management Team presented today at the Sidoti Year End Virtual Conference. Watch the replay here: https://sidoti.zoom.us/webinar/register/WN_ECZq8XevRqKfHf0YiznumA

0 · Reply

JohnTrack Dec. 11 at 4:08 PM

$IRIX watching for higher lows...

0 · Reply

Sidoti Dec. 11 at 3:32 PM

Day 2: Presenting at 10:45am at our Year End conference $IRIX $LZM $OBL https://buff.ly/lJdSLvw

0 · Reply

JohnTrack Dec. 11 at 12:17 PM

$IRIX new publication https://www.rapidticker.com/news/irix-iridex-announces-the-publication-of-e685dc

0 · Reply

10baggerPete Dec. 10 at 7:40 PM

$IRIX added based on the continued insider buying, I don't think tax loss selling will get it much lower. Bottom is in imho!

0 · Reply

Thestocktraderhubzee Dec. 8 at 12:16 PM

$IRIX Iridex Announces Newly Published Study In Translational Vision Science & Technology Examining Thermal Dynamics Of Transscleral Laser Treatments For Glaucoma

0 · Reply

DARKP00L Dec. 8 at 12:14 PM

$IRIX 07:08 on Dec. 08 2025 Iridex Announces Newly Published Study In Translational Vision Science & Technology Examining Thermal Dynamics Of Transscleral Laser Treatments For Glaucoma #tradeideas

1 · Reply

Suki444 Dec. 2 at 8:14 AM

$IRIX silent before the storm? Buyout in progress? $AMZN

0 · Reply

StudBull Dec. 1 at 8:49 PM

0 · Reply

StudBull Nov. 19 at 4:01 PM

$IRIX New Form 4 filing - Director William Moore buys another 50,000 shares via open market purchases

0 · Reply

StudBull Nov. 19 at 3:56 PM

$IRIX New Form 4 filing - Director William Moore buys another 50,000 shares via open market purchases

0 · Reply

StudBull Nov. 17 at 2:56 PM

$IRIX The Romeo is back

0 · Reply

stockanalysis_ Nov. 12 at 2:54 PM

Losers Today: $VSA $LFS $NTWK $GTI $IRIX Bookmark this page: https://stockanalysis.com/markets/losers/?ref=saveontrading

0 · Reply

bigtuna7 Nov. 12 at 2:50 PM

$IRIX Congrats shorts 😭

0 · Reply

inelegantinvest Nov. 11 at 9:58 PM

Not sure why $IRIX is down almost 25% after earnings. Basically breakeven, some revenue growth, guided EBITDA breakeven for full year. Trades now at less than .25 sales. When this rerates with profitability there's a lot of room to run.

2 · Reply

DARKP00L Nov. 11 at 9:25 PM

$IRIX 16:13 on Nov. 11 2025 IRIDEX shares are trading lower. The company reported Q3 financial results. #tradeideas

0 · Reply

lecorb Nov. 11 at 9:14 PM

$IRIX IRIDEX press release (IRIX): Q3 GAAP EPS of -$0.09. Revenue of $12.5M (+7.9% Y/Y). 2025 Financial OutlookThe Company plans to achieve cash flow breakeven in the fourth quarter and positive adjusted EBITDA in 2025 on revenue generation consistent with 2024

0 · Reply

bigtuna7 Nov. 11 at 9:08 PM

$IRIX Nice earnings

0 · Reply

StudBull Oct. 27 at 9:13 PM

$IRIX

0 · Reply

bigtuna7 Oct. 14 at 3:21 AM

$IRIX Conference coming up this weekend

0 · Reply

TradeTempo Oct. 5 at 8:13 AM

$IRIX Medical device niche. Thin volume trading. No technical edge. Avoid.

1 · Reply

bigtuna7 Oct. 3 at 3:38 PM

$IRIX Has that look man

0 · Reply

Market Cap	15.83M
Revenue (ttm)	48.67M
Net Income (ttm)	-8.91M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-18.31%
Debt to Equity Ratio	0.79

Volume	159,400
Avg Vol	77,598
Day's Range	N/A - N/A
Shares Out	17.19M
Stochastic %K	25%
Beta	0.65
Analysts	Strong Buy
Price Target	$2.00